Opioid Use Clinical Trial
Official title:
Observational Study to Characterize the Relationship Between Preoperative Depressive Symptoms and Opioid Use/Misuse After Surgery
| NCT number | NCT05412342 |
| Other study ID # | 43163 |
| Secondary ID | |
| Status | Enrolling by invitation |
| Phase | |
| First received | |
| Last updated | |
| Start date | May 10, 2019 |
| Est. completion date | June 2024 |
| Verified date | December 2023 |
| Source | Stanford University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
This observational study aims to characterize the relationship between preoperative depressive symptoms and opioid use/ misuse after surgery using a perioperative learning health care system. We will follow a prospective cohort of patients undergoing elective surgery.
| Status | Enrolling by invitation |
| Enrollment | 687 |
| Est. completion date | June 2024 |
| Est. primary completion date | March 2024 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: 1. Age 18+ 2. Planning to undergo surgery 3. English speaking 4. Ability and willingness to complete questionnaires and assessments Exclusion Criteria: 1. Any conditions causing inability to complete assessments (education, cognitive ability, mental status, medical status) 2. Known Pregnancy 3. Elevated Suicidality 4. Enrollment in a conflicting perioperative trial |
| Country | Name | City | State |
|---|---|---|---|
| United States | Stanford University School of Medicine | Palo Alto | California |
| United States | Stanford Health Care | Stanford | California |
| Lead Sponsor | Collaborator |
|---|---|
| Stanford University |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Time to Opioid Cessation | Assessed after surgery up to 1 year | ||
| Secondary | Opioid Misuse | Participant score on the Current Opioid Misuse Measure will be used to assess opioid misuse | Assessed after surgery up to 1 year |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04095624 -
Does Preoperative Pain Medication Management Influence Surgical Outcomes in Spinal Fusion
|
N/A | |
| Completed |
NCT04484610 -
Appropriate Opioid Quantities for Acute Pain - Pharmacist Study
|
Phase 4 | |
| Recruiting |
NCT04598074 -
Opioid Package Prototype (OPP)
|
N/A | |
| Recruiting |
NCT06033599 -
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
|
Phase 3 | |
| Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
| Completed |
NCT05845177 -
Persistent Pain After Hip Replacement
|
||
| Completed |
NCT03570320 -
Does Altering Narcotic Prescription Methods Affect Opioid Distribution Following Select Upper Extremity Surgeries?
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Completed |
NCT04526236 -
Influence of Aging on Perioperative Methadone Dosing
|
Phase 4 | |
| Completed |
NCT05593341 -
Opioid Education in Total Knee Arthroplasty
|
N/A | |
| Recruiting |
NCT06055205 -
A Pain and Coordination Plan for Reduced Opioid Use After Accidental Injuries
|
N/A | |
| Recruiting |
NCT05877157 -
Pain AND Opioids After Surgery
|
||
| Recruiting |
NCT03675386 -
Reducing Opioid Use for Chronic Pain Patients Following Surgery
|
N/A | |
| Suspended |
NCT05001789 -
Cognitive Functioning in Opioid Use Disorder
|
N/A | |
| Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
| Not yet recruiting |
NCT04868552 -
Naloxone Education in Total Joint Patients
|
N/A | |
| Completed |
NCT03540030 -
Opioid-Free Shoulder Arthroplasty
|
Phase 4 | |
| Terminated |
NCT06217380 -
Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program
|
N/A | |
| Recruiting |
NCT05976646 -
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
|
Phase 1/Phase 2 | |
| Terminated |
NCT03426137 -
Relieving Acute Pain (RAP) Study: A Pilot Study
|
Phase 2 |